Since 1998, OCRF has awarded 237 grants totaling $65 million for ovarian cancer research to top scientists at more than 60 leading medical centers. We invest our dollars wisely, supporting the best ovarian cancer research in the nation.
OCRF-funded projects have led to significant advances in such areas as early detection, diagnosis, genetics, prevention, treatments, and enhancing quality of life. In just the past year, OCRF funded researchers have:
- Identified a biomarker that may predict treatment response
- Shed new light on ovarian cancer metastasis
- Demonstrated how ovarian tumors elude the immune system
- Developed an experimental “chemoimmunotherapy” treatment for women with recurrent ovarian cancer
- Shown that glycans can identify ovarian cancer
- Discovered a fusion gene common in ovarian cancer
- Shown how epigenomic strategies efficiently target ovarian cancer stem cells
- Revealed how mesothelial cells promote ovarian cancer metastasis
The results of OCRF-supported research projects have been published in some of the world’s most prestigious journals, such as: Gynecologic Oncology, Lancet Oncology, New England Journal of Medicine, Cancer Research, Clinical Cancer Research, Journal of Clinical Oncology, Science Translational Medicine, Cancer Discovery and Nature.